Corcept Therapeutics Incorporated CORT

Updated: 12 Sep 2026

NASDAQ | Biotech | Biopharmaceuticals

No signal published yet

We already track Corcept Therapeutics and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Corcept Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biopharmaceuticals
We're already tracking Corcept Therapeutics Incorporated — here are the latest events we've registered

Recent News

  • On July 29, 2026, Corcept reported second-quarter 2026 revenue of $256.1 million, a 32 percent increase year-over-year, driven by strong demand for its Cushing's syndrome treatment and initial sales from Lifyorli. Net income reached $43.0 million for the quarter, compared to $35.1 million in the second quarter of 2025. Following the strong performance, the company raised its full-year 2026 revenue guidance to between $1.1 billion and $1.2 billion.

What Firelda Watch includes for Corcept Therapeutics Incorporated

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Corcept Therapeutics Incorporated will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Vicore Pharma Holding AB (publ)
VICO
HOLD
Cereno Scientific B
CRNO B
NEUTRAL
Moderna, Inc.
MRNA
HOLD
AstraZeneca PLC
AZN
HOLD
Calliditas Therapeutics
CALT
NEUTRAL

Biotech

More companies in this sector

Want to follow Corcept Therapeutics Incorporated? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Corcept Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Corcept Therapeutics Incorporated CORT
Corcept Therapeutics — follow and we'll monitor it
Follow Corcept Therapeutics free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.